Dargen 40

Dargen 40 Specification

Indication
Treatment of anemia in chronic renal failure or cancer chemotherapy

Origin of Medicine
India

Packaging Type
Prefilled Syringe

Salt Composition
Darbepoetin Alfa

Dosage Form
Injection

Pacakaging (Quantity Per Box)
1 x 0.40 ml prefilled syringe

Brand Name
Dargen 40

Life Span
See expiry date on package

Drug Type
Biological / Erythropoiesis-Stimulating Agent

Ingredients
Darbepoetin Alfa

Physical Form
Injection

Function
Stimulates erythropoiesis (production of red blood cells)

Recommended For
Anemia due to chronic kidney disease or chemotherapy

Dosage
As prescribed by physician

Dosage Guidelines
Administered subcutaneously or intravenously as prescribed

Suitable For
Adults and Children

Quantity
40 mcg

Storage Instructions
Store in a refrigerator (2C - 8C). Do not freeze.

Prescription/Non Prescription
Prescription only

Color/Appearance
Clear, colorless liquid

Batch/Lot Number
Mentioned on the box

Common Side Effects
Hypertension, headache, injection site reactions

Contraindications
Hypersensitivity to Darbepoetin alfa or any inactive ingredients

Product Code
DARGEN40INJ

Regulatory Approval
Approved by regulatory agencies as per national guidelines

Route of Administration
Subcutaneous or intravenous injection

MRP
As per pack/label at time of purchase

Dargen 40 Trade Information

Minimum Order Quantity
10 Pieces

Delivery Time
5-7 Days

About Dargen 40

Order the latest Dargen 40, a first-rate biotechnology product designed with valiant efficacy to fight anemia in adults and children. This breathtaking injection contains darbepoetin alfa (40 mcg/0.40 ml), delivered in a prefilled syringe for precise subcutaneous or intravenous administration. Dargen 40 stimulates the production of red blood cells, providing therapeutic benefits for patients with anemia linked to chronic kidney conditions or cancer chemotherapy. Purchase with confidence, knowing each solution is clear, colourless to pale yellow, made in India to premium standards. Prescription required.

Dargen 40: Purpose, Usage, and Application

Dargen 40 is expertly used for managing anemia due to chronic kidney disease or chemotherapy, offering targeted therapy in adults and children. Specifically formulated for subcutaneous or intravenous use, its medical application demands supervision by healthcare professionals. The product is not intended for plant or agricultural industry use, focusing solely on clinical needs. Administer Dargen 40 as directed by your physician to harness its full potential against anemia in affected individuals.

Dargen 40 Certifications and Export Logistics

Dargen 40 meets stringent industry certifications for premium pharmaceutical quality, ensuring reliability during transportation and handover to international clients. Its main export markets include Asia and Africa, supported by a robust sample policy for trusted partners. The journey from supplier to end user is handled with utmost care, guaranteeing that each unit arrives in optimal refrigerated condition, preserving the efficacy and quality expected of a first-rate biotechnology product.

FAQ's of Dargen 40:

Q: How should Dargen 40 be administered for optimal effectiveness?

A: Dargen 40 should be given either subcutaneously or intravenously as prescribed by your healthcare provider, strictly following the physician's dosage and frequency instructions.

Q: What are the main benefits of using Dargen 40 in anemia management?

A: Dargen 40 stimulates erythropoiesis, the production of red blood cells, offering significant relief from anemia associated with chronic kidney disease or chemotherapy, improving overall quality of life.

Q: When is Dargen 40 contraindicated for use?

A: This medication should not be used in individuals with uncontrolled hypertension or known hypersensitivity to darbepoetin alfa.

Q: Where should Dargen 40 be stored to maintain its effectiveness?

A: Store Dargen 40 in a refrigerator at 2C to 8C. Do not freeze the solution to ensure that the product remains effective until its expiry date.

Q: What process should be followed before starting Dargen 40 therapy?

A: Patients should undergo hemoglobin level tests and medical assessment. Use of Dargen 40 must be commenced and monitored under medical supervision only.